Comment on

• Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group.

  Gleave ME, Elhilali M, Fradet Y, Davis I, Venner P, Saad F, Klotz LH, Moore MJ, Paton V, Bajamonde A. Gleave ME, et al. N Engl J Med. 1998 Apr 30;338(18):1265-71. doi: 10.1056/NEJM199804303381804. N Engl J Med. 1998. PMID: 9562580 Clinical Trial.
• Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.

  Negrier S, Escudier B, Lasset C, Douillard JY, Savary J, Chevreau C, Ravaud A, Mercatello A, Peny J, Mousseau M, Philip T, Tursz T. Negrier S, et al. N Engl J Med. 1998 Apr 30;338(18):1272-8. doi: 10.1056/NEJM199804303381805. N Engl J Med. 1998. PMID: 9562581 Clinical Trial.